Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK)
Market: HKEX |
Currency: HKD
Address: One Taikoo Place
Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People's Republic of China. It offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. The company is also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology business. The company was incorporated in 2002 and is based in Quarry Bay, Hong Kong. Shenzhen Neptunus Interlong Bio-technique Company Limited is a subsidiary of Shenzhen Neptunus Bio-engineering Company Limited.
Show more
📈 Shenzhen Neptunus Interlong Bio-technique Company Limited Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
-
-
Upside/Downside from Analyst Target:
-
-
Broker Call:
-
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
<0%
-
Net Income Growth Range (1Y):
<0%
-
Revenue Growth Range (1Y):
<0%
💰 Dividend History
| Year |
Annual Yield (%) |
Total Amount |
Current Yield (%) |
Ex Date |
Pay Date |
Particulars |
| 2025 |
- |
$0.151330 |
- |
2025-05-15 |
- |
Dividend payout |
|
Total Amount for 2025: $0.151330 |
📅 Earnings & EPS History for Shenzhen Neptunus Interlong Bio-technique Company Limited
| Date | Reported EPS |
|---|
| 2025-08-20 (estimated upcoming) | - |
| 2025-05-25 | - |
| 2025-03-24 | - |
📰 Related News & Research
No related articles found for "shenzhen neptunus".
